Number and status of medicinal cannabis product approvals
B. Haddock made this Official Information request to Ministry of Health
The request was successful.
      From: B. Haddock
      
    
    Dear Ministry of Health / Medicinal Cannabis Agency,
I understand that various medicinal cannabis products are currently undergoing reviews to become approved medicines. This includes MediPharm Labs products, which Helius Therapeutics Ltd and Cannasouth Ltd have entered in to supply agreements for.
Can you please supply a list of products that:
1. Have been considered for approval as approved medicines, with a final outcome decided.
2. Were not considered for approval as approved medicines, as they did not meet basic or qualifying criteria. 
3. Are currently under consideration for approval as approved medicines.
For point #3 above, I would appreciate any information around expected timelines for approval. Alternatively, a statement of whether you expect additional cannabis products as approved medicines (beyond Sativex) to be available on the market this year.
Thank you for your time
B Haddock
        From: OIA Requests
      
    
    Kia ora
 Thank you for your requests for official information received on 27
 October 2020 for:
"I understand that various medicinal cannabis products are currently
 undergoing reviews to become approved medicines. This includes MediPharm
 Labs products, which Helius Therapeutics Ltd and Cannasouth Ltd have
 entered in to supply agreements for.
Can you please supply a list of products that:
 1. Have been considered for approval as approved medicines, with a final
 outcome decided.
 2. Were not considered for approval as approved medicines, as they did not
 meet basic or qualifying criteria.
 3. Are currently under consideration for approval as approved medicines."
The Ministry's reference number for your request is: H202007996.
 As required under the Official Information Act 1982, the Ministry will
 endeavour to respond to your request no later than 24 November 2020, being
 20 working days after the day your request was received.  
 If we are unable to respond to your request within this time frame, we
 will notify you of an extension of that time frame.
 If you have any queries related to this request, please do not hesitate to
 get in touch.
 Ngā mihi
 OIA Services
 Government Services
 Office of the Director-General
 Ministry of Health
 E: [email address]
--------------------------------------------------------------------------
From: B. Haddock <[FOI #14043 email]>
 Sent: Tuesday, 27 October 2020 20:44
 To: OIA Requests <[email address]>
 Subject: Official Information request - Number and status of medicinal
 cannabis product approvals
  
 Dear Ministry of Health / Medicinal Cannabis Agency,
I understand that various medicinal cannabis products are currently
 undergoing reviews to become approved medicines. This includes MediPharm
 Labs products, which Helius Therapeutics Ltd and Cannasouth Ltd have
 entered in to supply agreements for.
Can you please supply a list of products that:
 1. Have been considered for approval as approved medicines, with a final
 outcome decided.
 2. Were not considered for approval as approved medicines, as they did not
 meet basic or qualifying criteria.
 3. Are currently under consideration for approval as approved medicines.
For point #3 above, I would appreciate any information around expected
 timelines for approval. Alternatively, a statement of whether you expect
 additional cannabis products as approved medicines (beyond Sativex) to be
 available on the market this year.
Thank you for your time
 B Haddock
-------------------------------------------------------------------
This is an Official Information request made via the FYI website.
Please use this email address for all replies to this request:
 [FOI #14043 email]
Is [Ministry of Health request email] the wrong address for Official Information requests
 to Ministry of Health? If so, please contact us using this form:
 [1]https://scanmail.trustwave.com/?c=15517&...
Disclaimer: This message and any reply that you make will be published on
 the internet. Our privacy and copyright policies:
 [2]https://scanmail.trustwave.com/?c=15517&...
If you find this service useful as an Official Information officer, please
 ask your web manager to link to us from your organisation's OIA or LGOIMA
 page.
show quoted sections
This e-mail message has been scanned for Viruses and Content and cleared
 by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
References
Visible links
 1. https://scanmail.trustwave.com/?c=15517&...
 2. https://scanmail.trustwave.com/?c=15517&...
        From: Caitlin Finnegan-Ramanui
      
    
    Kia ora B Haddock
Thank you for your request for official information, received on 27
 October 2020 requesting:
“I understand that various medicinal cannabis products are currently
 undergoing reviews to become approved medicines. This includes MediPharm
 Labs products, which Helius Therapeutics Ltd and Cannasouth Ltd have
 entered in to supply agreements for.
 Can you please supply a list of products that:
 1. Have been considered for approval as approved medicines, with a final
 outcome decided.
 2. Were not considered for approval as approved medicines, as they did not
 meet basic or qualifying criteria.
 3. Are currently under consideration for approval as approved medicines.”
The Ministry of Health has decided to extend the period of time available
 to respond to your request under section 15A of the Official Information
 Act 1982 (the Act) as further consultation is required.
You can now expect a response to your request on, or before, 4 December
 2020.
You have the right, under section 28 of the Act, to ask the Ombudsman to
 review my decision to extend the time available to respond to your
 request.
Ngâ mihi
 
Caitlin Finnegan-Ramanui
 Advisor | OIA Services
 Office of the Director-General
 Ministry of Health
 E: [1][email address]
 L1 North, Yellow, 113 Molesworth St, Wellington
 
show quoted sections
References
Visible links
 1. mailto:[email address]
        From: Caitlin Finnegan-Ramanui
      
    
    Kia ora B Haddock
 
Please find attached the response to your request for official
 information.
 
Nga mihi,
 
Caitlin Finnegan-Ramanui
 Advisor | OIA Services
 Office of the Director-General
 Ministry of Health
 E: [1][email address]
 L1 North, Yellow, 113 Molesworth St, Wellington
 
show quoted sections
References
Visible links
 1. mailto:[email address]
      From: B. Haddock
      
    
    Kia Ora Caitlin,
Thank you for the considered and detailed response - I really appreciate it.
Nga mihi,
B. Haddock
Things to do with this request
- Add an annotation (to help the requester or others)
 - Download a zip file of all correspondence (note: this contains the same information already available above).
 

